KENNETH DORITY, D.O.
Addiction Medicine (Family Medicine) Physician in ARLINGTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: KENNETH DORITY, D.O. reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 86 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
KENNETH DORITY, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
KENNETH DORITY, D.O. at a glance
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Addiction Medicine (Family Medicine) Physician compares to other specialties among Texas providers
Addiction Medicine (Family Medicine) Physician share within Texas
Addiction Medicine (Family Medicine) Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
KENNETH DORITY, D.O.'s 2023 MIPS final score plotted against the Addiction Medicine (Family Medicine) Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Addiction Medicine (Family Medicine) Physician) — 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Addiction Medicine (Family Medicine) Physician US NPIs
100/100 MIPS final score — 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Addiction Medicine (Family Medicine) Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KENNETH DORITY, D.O. is a Addiction Medicine (Family Medicine) Physician provider practicing in ARLINGTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1659313328. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
KENNETH DORITY, D.O. appears in the CMS NPPES registry as a Addiction Medicine (Family Medicine) Physician provider holding D.O. credentials at 2912 KRAFT ST STE 30, ARLINGTON, TX, 76010, with a listed phone of (402) 885-0365. NPI 1659313328 was issued on 06/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DORITY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 86 prescription claims written by this provider, covering 25 Medicare beneficiaries and totaling roughly $17K in drug spend, split 28% brand-name and 72% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.
Addiction Medicine (Family Medicine) Physician is a narrow specialty nationwide, with 763 enrolled providers across 48 states and an average of 1,134 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1659313328 |
|---|---|
| Specialty | Addiction Medicine (Family Medicine) Physician |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 06/10/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KENNETH DORITY, D.O.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KENNETH DORITY, D.O.. Source: openpaymentsdata.cms.gov.
Total received
$735
Largest payer
Corium, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to KENNETH DORITY, D.O.. To verify KENNETH DORITY, D.O.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
28% brand-name claims vs 72% generic, on 86 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 86
- Total Day Supply
- 1,533
- Brand vs Generic
- 28% brand / 72% generic
- Brand Drug Cost
- $9K
- Generic Drug Cost
- $8K
Patient Demographics
- Average Patient Age
- 60.8 years
- Avg HCC Risk Score
- 1.79
- Age Distribution
- <65: 11, 65-74: 14, 75-84: 0, 85+: 0
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 46 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Addiction Medicine (Family Medicine) Physician Overview
How KENNETH DORITY, D.O. fits within the Addiction Medicine (Family Medicine) Physician landscape nationally.
KENNETH DORITY, D.O.'s 86 claims are below the specialty average of 1,134.
Nearby Addiction Medicine (Family Medicine) Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as DORITY.
Compare Addiction Medicine (Family Medicine) Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is KENNETH DORITY, D.O.'s specialty? ▼
How much does KENNETH DORITY, D.O. prescribe under Medicare Part D? ▼
What is KENNETH DORITY, D.O.'s Medicare quality score? ▼
Where is KENNETH DORITY, D.O. located? ▼
What is KENNETH DORITY, D.O.'s NPI number? ▼
Does KENNETH DORITY, D.O. prescribe more brand-name or generic drugs? ▼
How many Addiction Medicine (Family Medicine) Physician providers are there in the US? ▼
What drugs does KENNETH DORITY, D.O. prescribe most often? ▼
Does KENNETH DORITY, D.O. accept Medicare? ▼
How can I verify KENNETH DORITY, D.O.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology